Agendia's Unattributed Round

Agendia raised a round of funding on July 25, 2018. Investors include Athyrium Capital Management.

Agendia is a privately held, leading molecular diagnostics company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decision…

Articles about Agendia's Unattributed Round: